Firm at a glance
Vallis Capital Partners is a platform private equity firm founded in 2010, per its own website [S1]. The firm reports over €200M in assets under management as of 2025, with its current fund vintage dating to 2019 [S1].
What they buy
Vallis Capital Partners appears to concentrate on Portuguese and Iberian platform businesses across healthcare and business services sectors, based on its publicly disclosed portfolio [S2]. The firm’s healthcare investments span dental clinics, hair transplant services, and disposable medical products manufacturing [S2]. Beyond healthcare, the firm has acquired businesses in temperature-controlled logistics, event production and audiovisual equipment rental, and document management outsourcing [S2].
Portfolio
Healthcare
Vallis Capital Partners holds three healthcare platforms. Smile.up, a dental medicine business acquired in 2013, represents the firm’s longest-held investment [S2]. ARKA, an industrial manufacturer of disposable products for the healthcare sector, joined the portfolio in 2016 [S2]. Saúde Viável / Insparya, a hair transplant services provider, was acquired in 2019 [S2].
Logistics and Business Services
Zolve, a temperature-controlled logistics provider, entered the portfolio in 2020 [S2]. Europalco, which provides event production services and audiovisual equipment rental, was acquired in 2023 [S2]. Docout, an outsourcing provider for critical processes and document management, also joined in 2023 [S2].
Recent activity (last 24 months)
* Acquired Europalco, an event production and audiovisual equipment rental company, in 2023 [S2]
* Acquired Docout, a document management and critical process outsourcing provider, in 2023 [S2]
* Exited Castelbel in 2023 [S2]
How this firm fits a seller
Vallis Capital Partners appears to pursue a platform-focused strategy, acquiring founder-led or family-owned businesses in Portugal and the broader Iberian market. The firm’s portfolio demonstrates a willingness to hold investments for extended periods, with Smile.up remaining in the portfolio since 2013 [S2]. For sellers in healthcare services, specialized logistics, or business process outsourcing, particularly those operating in Portuguese-speaking markets, the firm’s sector focus and demonstrated exit activity may represent a relevant fit. The firm’s 2023 exit of Castelbel indicates active portfolio management and realization activity [S2].
Sources
[S1] https://vallis.pt (as of 2025-01-15)
[S2] https://vallis.pt/portfolio/ (as of 2025-01-15)
Frequently asked questions
Does Vallis Capital Partners buy healthcare businesses?
Yes, healthcare represents a significant portion of the firm’s investment activity. Vallis Capital Partners holds three healthcare platforms spanning dental services (Smile.up), disposable medical products manufacturing (ARKA), and hair transplant services (Saúde Viável / Insparya), acquired between 2013 and 2019 [S2].
What companies has Vallis Capital Partners acquired recently?
The firm’s most recent acquisitions include Europalco, an event production and audiovisual equipment rental business, and Docout, a document management and critical process outsourcing provider, both acquired in 2023 [S2]. The firm also completed an exit of Castelbel in 2023 [S2].
Where is Vallis Capital Partners based and how big is the firm?
Vallis Capital Partners reports over €200M in assets under management, with its current fund vintage dating to 2019 [S1]. The firm was founded in 2010 [S1]. Specific office locations were not disclosed in publicly available materials reviewed.
Is Vallis Capital Partners still actively acquiring?
Yes, the firm completed two platform acquisitions in 2023 (Europalco and Docout), indicating active investment activity [S2]. The firm’s current fund vintage dates to 2019, suggesting it remains in an active deployment period [S1].
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.